Medicines for Europe 17th Legal Affairs Conference 2023

Home/Conferences | Posted 20/04/2023 post-comment0 Post your comment

Medicines for Europe 17th Legal Affairs Conference 2023
13 June 2023
Hilton Hotel

MedEU logo V23D20LT

With critical discussions around the revision of the pharmaceutical and intellectual property (IP) legislation in Europe, this Conference will be a timely and unmissable opportunity to shape European policies that will influence the pharmaceutical business and healthcare systems for decades to come.

Attendees will have the opportunity to discuss the main IP and competition issues in the pharmaceutical sector with leading industry executives, experts, counsel and European institution officials.

The conference will feature:

  • A high level General Counsel discussion
  • A debate on the revised pharmaceutical legislation, including modulation of exclusivities, Bolar Exemption and other features
  • A discussion on the latest developments on the Supplementary Protection Certificate (SPC), including the implementation of the SPC manufacturing waiver and the unified patent/SPC system
  • A reflection on competition law and the quality of the European patent system
  • A review of existing patent linkages in EU Member States, and ways to address them

Don’t miss this opportunity to attend our event and join in shaping discussions at interactive roundtables on topics including competition policies, antitrust challenges, data protection, second medical use patents, alternative dispute resolutions, preliminary injunctions and compensation rules, and more …

For more details, visit:

comment icon Comments (0)
Post your comment
Related content
28th Medicines for Europe Annual Conference 2023
MedEU logo V23D20LT
Home/Conferences Posted 20/04/2023
DIA Europe 2023 – a brief report
DIA logo V23D20LT
Home/Conferences Posted 20/04/2023
1st ASBM/GaBI biosimilar webinar on biosimilars uptake
ASBM 2022 Webinar 1 Banner Square V22G25LT replay
Home/Conferences Posted 26/08/2022
Most viewed articles
About GaBI
Home/About GaBI Posted 06/08/2009
EU guidelines for biosimilars
EMA logo 1 V13C15
Home/Guidelines Posted 08/10/2010